Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston May 25, 2022 8:49am
203 Views
Post# 34705864

RE:RE:RE:RE:RE:RE:RE:RE:Insiders continue to Buy 750 k in warrants May 14 2022

RE:RE:RE:RE:RE:RE:RE:RE:Insiders continue to Buy 750 k in warrants May 14 2022

NotinKansas ... Great post.  

Indeed, why would Roger and Kristina have both risked their own money if that was to go south!  

At this point in time, 35% into a Ph. 2, they know what's coming (FDA Breakthrough designation, potential discussions with a jv partner, etc ...).  We just need more data.  And access to that data is worth approx. 500M$US as per the industry guidelines and supported by an article in Nature journal recently posted.  We just need this trigger event that will move this stock to a valuation that compares more or less to those of other competitors.


______________
 

RE:RE:RE:RE:RE:RE:RE:Insiders continue to Buy 750 k in warrants May 14 2022

To me, Rodger and Kristina’s willingness to invest another $225k in the company at this point signals not only that they feel confident about the company’s future, but also that they do not see another low ball placing coming. Otherwise, they surely would have kept their powder dry, I’d think. It gives me considerable peace of mind.
<< Previous
Bullboard Posts
Next >>